Cargando…

N-terminal Pro-Brain Natriuretic Peptide And Atrial Fibrillation

NT-proBNP is produced from both atria and ventricles. The primary regulation of production is at the synthesis level. The plasma half-life of NT-proBNP is 60-120 min. Cutoff value of NT-proBNP for diagnosis of heart failure is 125 pg/ml in the age group below 75 years and 450 pg/ml in the age group...

Descripción completa

Detalles Bibliográficos
Autores principales:	Thejus, Jayachandran, Francis, Johnson
Formato:	Texto
Lenguaje:	English
Publicado:	Indian Heart Rhythm Society 2009
Materias:	Editorial
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2615056/ https://www.ncbi.nlm.nih.gov/pubmed/19165353

Ejemplares similares

Relationship of atrial fibrillation and N terminal pro brain natriuretic peptide in heart failure patients
por: Nasab Mehrabi, Entezar, et al.
Publicado: (2023)

N‐Terminal Pro Brain, N‐Terminal Pro Atrial Natriuretic Peptides, and Dynamic Cerebral Autoregulation
por: Mahinrad, Simin, et al.
Publicado: (2020)

Atrial fibrillation in Cardiac Channelopathies
por: Thejus, Jayachandran, et al.
Publicado: (2009)

Radiofrequency Ablation In Ventricular Fibrillation
por: Thejus, Jayachandran, et al.
Publicado: (2008)

N‐terminal pro brain natriuretic peptide eliminates the prognostic effect of atrial fibrillation in patients with chronic heart failure
por: Schnorbach, Johannes, et al.
Publicado: (2019)

Supraventricular arrhythmia, N-terminal pro-brain natriuretic peptide and troponin T concentration in relation to incidence of atrial fibrillation: a prospective cohort study
por: Xiao, Jun, et al.
Publicado: (2021)

Utility of point-of-care testing of natriuretic peptides (brain natriuretic peptide and n-terminal pro-brain natriuretic peptide) in the emergency department
por: Nayer, Jamshed, et al.
Publicado: (2014)

Correlation between N-Terminal Pro-Brain Natriuretic Peptide and Doppler Echocardiographic Parameters of Left Ventricular Filling Pressure in Atrial Fibrillation
por: Kim, Woo Shin, et al.
Publicado: (2011)

N-terminal pro brain natriuretic peptide in coronary artery disease
por: Tin, Sim Sai, et al.
Publicado: (2015)

Assessment of N-terminal pro-B-type natriuretic peptide level in screening for atrial fibrillation in primary health care
por: Ghazal, Faris, et al.
Publicado: (2019)

Levels of N-terminal pro-brain natriuretic peptide in brain injury patients
por: Tsentsiper, L, et al.
Publicado: (2015)

Relationship of diabetes, heart failure, and N‐terminal pro‐B‐type natriuretic peptide with cardiovascular outcomes in patients with atrial fibrillation
por: Hofer, Felix, et al.
Publicado: (2022)

Reply to: N-terminal pro brain natriuretic peptide in coronary artery disease
por: Radwan, Hanan, et al.
Publicado: (2015)

Artificial Intelligence-Enabled Electrocardiography Detects B-Type Natriuretic Peptide and N-Terminal Pro-Brain Natriuretic Peptide
por: Liu, Pang-Yen, et al.
Publicado: (2023)

Value of N-Terminal Pro-Brain Natriuretic Peptide for Embolic Events Risk Prediction in Patients with Atrial Fibrillation; a Systematic Review and Meta-Analysis
por: Ahmadzadeh, Koohyar, et al.
Publicado: (2023)

Plasma N-terminal pro-atrial natriuretic peptide concentrations are affected by dehydration in healthy dogs
por: Ogawa, Mizuki, et al.
Publicado: (2023)

Do the Natriuretic Peptides Cause Atrial Fibrillation or is it Not So Black and White?
por: Richards, Arthur Mark
Publicado: (2019)

Plasma atrial natriuretic peptide and N-terminal pro B-type natriuretic peptide concentrations in dogs with right-sided congestive heart failure
por: KANNO, Nobuyuki, et al.
Publicado: (2015)

N-terminal pro-brain natriuretic peptide levels had an independent and added ability in the evaluation of all-cause mortality in older Chinese patients with atrial fibrillation
por: Fu, Shihui, et al.
Publicado: (2019)

N-terminal pro atrial natriuretic peptide as a prognostic marker of cardiac resynchronization therapy recipients
por: Ueda, Nobuhiko, et al.
Publicado: (2023)

N‐terminal pro‐B‐type natriuretic peptide and D‐dimer combined with left atrial diameter to predict the risk of ischemic stroke in nonvalvular atrial fibrillation
por: Shen, Zican, et al.
Publicado: (2022)

N-Terminal Pro B-Type Natriuretic Peptide's Usefulness for Paroxysmal Atrial Fibrillation Detection Among Populations Carrying Cardiovascular Risk Factors
por: Palà, Elena, et al.
Publicado: (2019)

Effects of Atrial Fibrillation Screening According to N-Terminal Pro-B-Type Natriuretic Peptide: A Secondary Analysis of the Randomized LOOP Study
por: Xing, Lucas Yixi, et al.
Publicado: (2023)

Diagnostic and prognostic values of B-type natriuretic peptides (BNP) and N-terminal fragment brain natriuretic peptides (NT-pro-BNP)
por: Maries, Lorena, et al.
Publicado: (2013)

Effects of glutamine and valsartan on the brain natriuretic peptide and N-terminal pro-B-type natriuretic peptide of patients with chronic heart failure
por: Shao, Mingliang, et al.
Publicado: (2015)

Midregional pro-atrial natriuretic peptide is a superior biomarker to N-terminal pro-B-type natriuretic peptide in the diagnosis of heart failure patients with preserved ejection fraction
por: Cui, Kun, et al.
Publicado: (2018)

N-Terminal Pro–B-Type Natriuretic Peptide as a Risk Biomarker for Stroke in a General Japanese Population
por: Tomita, Hirofumi
Publicado: (2020)

N-Terminal Pro–B-Type Natriuretic Peptide and Incident CKD
por: Sasaki, Takaya, et al.
Publicado: (2021)

The predictive value of brain natriuretic peptide or N-terminal pro-brain natriuretic peptide for weaning outcome in mechanical ventilation patients: Evidence from SROC
por: Liu, Jian, et al.
Publicado: (2021)

NH(2)-Terminal Pro–Brain Natriuretic Peptide and Risk of Diabetes
por: Lazo, Mariana, et al.
Publicado: (2013)

Predictive value of N-terminal pro-brain natriuretic peptide among critically ill patients
por: Cubrilo-Turek, M, et al.
Publicado: (2012)

Perioperative application of N-terminal pro-brain natriuretic peptide in patients undergoing cardiac surgery
por: Liu, Hua, et al.
Publicado: (2013)

Serial Measurements of N-Terminal Pro-Brain Natriuretic Peptide in Patients with Coronary Heart Disease
por: Dallmeier, Dhayana, et al.
Publicado: (2015)

Age-adjusted plasma N-terminal pro-brain natriuretic peptide level in Kawasaki disease
por: Jun, Heul, et al.
Publicado: (2016)

N-terminal-pro brain natriuretic peptides in dogs and cats: A technical and clinical review
por: de Lima, Gabriela Vieira, et al.
Publicado: (2017)

Association of N- terminal Pro Brain Natriuretic Peptide with Echocardiographic Measures of Diastolic Dysfunction in Cirrhosis
por: Singh, Ajmera Jail, et al.
Publicado: (2020)

Assessment of the impact of different N terminal pro brain natriuretic peptide thresholds on echocardiography services
por: Yii, Eric, et al.
Publicado: (2021)

N‐terminal pro brain natriuretic peptide reference values in community‐dwelling older adults
por: Braisch, Ulrike, et al.
Publicado: (2022)

N-terminal pro-brain natriuretic peptide and adverse outcomes in Chinese patients with hypertrophic cardiomyopathy
por: Zhang, Zeng-Lei, et al.
Publicado: (2022)

N-Terminal Pro-Brain Natriuretic Peptide Levels Are Associated with Post-Stroke In-Hospital Complications
por: Ruiz-Franco, María Luisa, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_doqpm0n8gl2vpsbqs072af9ba9